logo-loader
ResearchHealth
viewJudges Scientific PLC

Judges Scientific Plc - Another period of solid growth

 

Judges Scientific posted further record highs across the board for the first half of 2019 purely driven by organic growth. Revenues were up 9% year-on-year to a record £40.2mln largely thanks to strong growth in North America while other regions remained generally stable with low single-digit ups and downs. Order intake in the first half (1H) of 2019 grew 4% year-on-year, which is well on track with the full-year expectation, with a solid order book of 13.2 weeks. Overall order intake was strong across the regions with double-digit growth year-on-year except in the UK where it was down 22%.

Adjusted operating profit increased 26% to £8.6mln with margin improvement to 21% from 19% in 1H 2018. Such a notable improvement is attributable to increased order intake and a continued drive to optimise operational performance, plus the group reduced customer delivery lead times, hence the one-off performance contribution from a 1.2-week order book compression during the period.

Cash flow during 1H 2019 remained healthy and the group finished 1H with adjusted net cash of £7.4mln, up from £0.9mln at the beginning of 2019.

Quick facts: Judges Scientific PLC

Price: 4430 GBX

AIM:JDG
Market: AIM
Market Cap: £275.58 m
Follow

What's in the report?

Financial results and forecasts
Growth drivers
Management
Market conditions
Milestones & inflection points

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

LEGAL NOTICE – IMPORTANT – PLEASE READ:

Proactive Research is a trading name of Proactive Investors Limited which is regulated and authorised by the Financial Conduct Authority (FCA) under firm registration...

FOR OUR FULL DISCLAIMER CLICK HERE

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

Watch

Polar Capital Global Healthcare's Daniel Mahony talks key sector developments

Polar Capital Global Healthcare's (LON:PCGH) Daniel Mahony talks through the key developments he's seeing in the healthcare sector at the moment in addition to the impact of political issues stemming from the US. He also discusses how IT is beginning to disrupt the healthcare landscape.

18 hours, 30 minutes ago

2 min read